Glatt

Overview

Glatt Pharmaceutical Services supports pharmaceutical and biotech companies through every stage of drug product development, from initial formulation design to large-scale commercial manufacturing. The company specializes in complex oral solid dosage forms and multiparticulate systems, leveraging more than 70 years of expertise in fluidized bed technology.

Core Services

Development & Formulation

• Early-stage formulation development
• Analytical method development and stability testing
• Solid-state characterization and process development
• Technology transfer and scale-up from lab to commercial production

Manufacturing Capabilities

• Clinical trial supply production
• Commercial-scale contract manufacturing
• Multiparticulate manufacturing (pellets, micropellets, granules)
• Advanced drug delivery technologies: controlled release, modified release, taste masking, drug layering
• Solubility enhancement via amorphous solid dispersions, hot-melt extrusion, and granulation
• Handling of sensitive and high-potency APIs
• Pediatric, geriatric, and animal health formulations

Process Technologies

• Fluidized bed systems (spray granulation, coating, drying)
• Wurster coating for functional coatings and modified release
• Spray granulation and agglomeration
• Microencapsulation
• Extrusion and pelletization

Additional Services

• Life cycle management and consulting
• Quality assurance and analytical services
• Plant engineering and process optimization

Regulatory & Quality

Glatt conducts all requisite analytical studies and stability tests to support seamless scale-up and regulatory submissions. The company operates with stringent quality standards and cGMP compliance for clinical and commercial supply.

Global Reach

Glatt operates worldwide with 18 locations and serves over 160 countries, supported by 58 representatives globally.